Additional Locations, Massachusetts Clinical Trials

A listing of Additional Locations, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 112 clinical trials
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Dana-Farber Cancer Institute
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Efficacy and Safety of Teicoplanin in CDAD

Primary Objective: Explore the efficacy of teicoplanin (100-200 mg administered orally twice a day for 7 to 14 days) in patients with Clostridium difficile infection-associated diarrhea and colitis Secondary Objective: Evaluate the safety of teicoplanin in patients with Clostridium difficile infection-associated diarrhea and colitis

Boston Medical Center
 (4.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Acne_Trial_CheckOverallContact  

qa

US-Site 1
 (4.8 away)
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (SURVIVE)

The primary purpose of this study is to determine whether adding SurVaxM to standard chemotherapy with temozolomide is better than treatment with temozolomide alone for patients with newly diagnosed glioblastoma. This study is designed to compare the duration of survival in patients with newly diagnosed glioblastoma receiving temozolomide plus SurVaxM …

Dana Farber Cancer Institute
 (3.3 away) Contact site
  • 0 views
  • 02 Dec, 2024
  • +9 other locations
Personalized Performance Optimization Platform (P-POP)

Crews of future long-duration exploration missions will have to cope with a wide range of stressors that present significant challenges for maintaining optimal performance. Crews will have to operate under conditions of high workload, reduced sleep and circadian dysregulation, limited sensory stimulation, confinement and extended separation from family and friends, …

Accepts healthy volunteers
MIT Media Lab
 (3.6 away) Contact site
  • 0 views
  • 21 May, 2025
  • 1 location
Automated Inhaler Monitoring for Asthma Medication Usage (AIM)

The goal of this clinical trial is to evaluate the aflo™ digital platform's ability to improve inhaler use technique and asthma control for children, adolescents, and adults with uncontrolled asthma. The main questions the trial aims to answer are:Does the platform improve medication adherence and inhaler technique, as measured by …

Boston Children's Hospital
 (3.8 away) Contact site
  • 0 views
  • 20 Mar, 2026
  • 1 location
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

tirzepatide
cardiovascular disease
dulaglutide
body mass index
Joslin Diabetes Center
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +650 other locations
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

cancer therapy
immunomodulator
endometrial carcinoma
measurable disease
recurrent disease
Research Site
 (5.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +94 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

monoclonal antibody therapy
small cell lung cancer
immunodeficiency
platelet count
pemetrexed
Winchester Hospital
 (7.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC

This trial is to investigate whether pre-pectoral Implant-Based Breast Reconstruction (IBBR) provides better Quality of Life (QoL) with respect to long-term (24 months) physical well-being (chest) compared to sub-pectoral IBBR for patients undergoing skin-sparing mastectomy or nipple-sparing mastectomy for prevention or treatment of breast cancer.

mastectomy
breast reconstruction
cancer
breast cancer
Brigham and Women's Hospital Harvard Medical School
 (3.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +20 other locations